Herrero Ana; Pinto Adan; Colon-Bolea Paula; Casar Berta; Jones Mary; Agudo-Ibanez Lorena; Vidal Rebeca; Tenbaum Stephan P; Nuciforo Paolo; Valdizan Elsa M; Horvath Zoltan; Őrfi László; Pineda-Lucena Antonio; Bony Emilie; Kéri György; Rivas German; Pazos Angel; Gozalbes Rafael; Palmer Hector G; Hurlstone Adam; Crespo Piero
(2015)
Nearly 50% of human malignancies exhibit unregulated RAS-ERK signaling; inhibiting it is a valid strategy for antineoplastic intervention. Upon activation, ERK dimerize, which is essential for ERK extranuclear, but not for ...